Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease

Genome wide association studies have identified several genes that might be associated with increase susceptibility to Type 1 Diabetes (T1D) and Crohn's disease. Both Crohn's disease and T1D have a profound impact on the lives of patients and it is pivotal to investigate the genetic role in patients acquiring these diseases. Understanding the effect of single nucleotide polymorphisms (SNP's) in key genes in patients suffering from T1D and Crohn's disease is crucial to finding an effective treatment and generating novel therapeutic drugs. This review article is focused on the impact of SNP's in PTPN2 (protein tyrosine phosphatase, non-receptor type 2) and PTPN22 (protein tyrosine phosphatase non-receptor type 22) on the development of Crohn's disease and T1D. The PTPN2 gene mutation in T1D patients play a direct role in the destruction of beta cells while in Crohn's disease patients, it modulates the innate immune responses. The PTPN22 gene mutations also play a role in both diseases by modulating intracellular signaling. Examining the mechanism through which these genes increase the susceptibility to both diseases and gaining a better understanding of their structure and function is of vital importance to understand the etiology and pathogenesis of Type 1 Diabetes and Crohn's disease.

[1]  N. Bottini,et al.  PTPN22 Alters the Development of Regulatory T Cells in the Thymus , 2012, The Journal of Immunology.

[2]  P. Gregersen,et al.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. , 2011, The Journal of clinical investigation.

[3]  G. Rogler,et al.  Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. , 2013, Gastroenterology.

[4]  D. Hober,et al.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host , 2010, Nature Reviews Endocrinology.

[5]  P. Zheng,et al.  PTPN22 Silencing in the NOD Model Indicates the Type 1 Diabetes–Associated Allele Is Not a Loss-of-Function Variant , 2013, Diabetes.

[6]  H. Ploegh,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .

[7]  D. Fardo,et al.  Combining genetic association study designs: a GWAS case study , 2013, Front. Genet..

[8]  M. V. von Herrath,et al.  Type 1 diabetes: etiology, immunology, and therapeutic strategies. , 2011, Physiological reviews.

[9]  P. Marchetti,et al.  PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim , 2011, Diabetes.

[10]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis , 2010, Diabetes.

[11]  R. Sartor.  Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[12]  K. Cerosaletti,et al.  Protein Tyrosine Phosphatases and Type 1 Diabetes : Genetic and Functional Implications of PTPN 2 and PTPN 22 , 2013 .

[13]  S. Lei,et al.  Identification of novel risk genes associated with type 1 diabetes mellitus using a genome-wide gene-based association analysis , 2014, Journal of diabetes investigation.

[14]  Garth L Burn,et al.  Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? , 2011, FEBS letters.

[15]  Cisca Wijmenga,et al.  Shared and distinct genetic variants in type 1 diabetes and celiac disease. , 2008, The New England journal of medicine.

[16]  S. Naser,et al.  Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study , 2013, Gut Pathogens.

[17]  A. Nazemi,et al.  Prevalence of Mycobacterium avium subsp. paratuberculosis in Dairy Cattle Bred in Northern Iran by Nested-PCR , 2012 .

[18]  C. Hofmann,et al.  Crohn's disease‐associated polymorphism within the PTPN2 gene affects muramyl‐dipeptide‐induced cytokine secretion and autophagy , 2012, Inflammatory Bowel Diseases.

[19]  D. Chistiakov,et al.  T-cell protein tyrosine phosphatase: A role in inflammation and autoimmunity , 2010 .

[20]  N. Bottini,et al.  Autoimmunity-Associated LYP-W620 Does Not Impair Thymic Negative Selection of Autoreactive T Cells , 2014, PloS one.

[21]  Nunzio Bottini,et al.  Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant , 2005, Nature Genetics.

[22]  N. Bottini,et al.  Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. , 2005, Human immunology.

[23]  G. Rogler,et al.  Protein Tyrosine Phosphatase Nonreceptor Type 2 Regulates Autophagosome Formation in Human Intestinal Cells , 2012, Inflammatory bowel diseases.

[24]  G. Lichtenstein,et al.  Current and future anti-TNF therapy for inflammatory bowel disease , 2007, Current treatment options in gastroenterology.

[25]  K. Cerosaletti,et al.  Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22. , 2012, The review of diabetic studies : RDS.

[26]  J. Ilonen,et al.  Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes , 2006, Diabetologia.

[27]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[28]  G. Rogler,et al.  The role for protein tyrosine phosphatase nonreceptor type 2 in regulating autophagosome formation , 2012, Annals of the New York Academy of Sciences.

[29]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[30]  上田 裕紀.  Etiology of type 1 diabetes , 2011 .

[31]  D. Mccole.  Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2 , 2012, Annals of the New York Academy of Sciences.

[32]  G. Rogler,et al.  Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. , 2009, Gastroenterology.

[33]  B. Becher,et al.  PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis , 2014, Mucosal Immunology.

[34]  E. Urcelay,et al.  A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes , 2011, Immunogenetics.

[35]  S. Naser,et al.  Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients , 2000, American Journal of Gastroenterology.

[36]  G. Rogler,et al.  Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy , 2013, PloS one.

[37]  T. Tiganis,et al.  PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice. , 2014, Journal of autoimmunity.

[38]  J. Valentine,et al.  Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease , 2004, The Lancet.

[39]  F. Haj,et al.  Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice , 2014, Diabetologia.